BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 26468983)

  • 21. RIZ1: a potential tumor suppressor in glioma.
    Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
    BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical markers for prognosis of oligodendroglial neoplasms.
    Korshunov A; Golanov A; Sycheva R
    J Neurooncol; 2002 Jul; 58(3):237-53. PubMed ID: 12187958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma.
    Bourgonje AM; Verrijp K; Schepens JT; Navis AC; Piepers JA; Palmen CB; van den Eijnden M; Hooft van Huijsduijnen R; Wesseling P; Leenders WP; Hendriks WJ
    Acta Neuropathol Commun; 2016 Sep; 4(1):96. PubMed ID: 27586084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular profiles for insular low-grade gliomas with putamen involvement.
    Zhou C; Wang Y; Liu X; Liang Y; Fan Z; Jiang T; Wang Y; Wang L
    J Neurooncol; 2018 Jul; 138(3):659-666. PubMed ID: 29556911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RAB38 confers a poor prognosis, associated with malignant progression and subtype preference in glioma.
    Wang H; Jiang C
    Oncol Rep; 2013 Nov; 30(5):2350-6. PubMed ID: 24026199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of proliferation genes in formalin-fixed paraffin-embedded (FFPE) tissue from breast carcinomas. Feasibility and relevance for a routine histopathology laboratory.
    Thomas C; Robinson C; Dessauvagie B; Wood B; Sterrett G; Harvey J; Amanuel B
    J Clin Pathol; 2017 Jan; 70(1):25-32. PubMed ID: 27235535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction.
    van den Boom J; Wolter M; Blaschke B; Knobbe CB; Reifenberger G
    Int J Cancer; 2006 Nov; 119(10):2330-8. PubMed ID: 16865689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
    Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
    Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas.
    Cassoni P; Senetta R; Castellano I; Ortolan E; Bosco M; Magnani I; Ducati A
    Am J Surg Pathol; 2007 May; 31(5):760-9. PubMed ID: 17460461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ALDH1A3: A Marker of Mesenchymal Phenotype in Gliomas Associated with Cell Invasion.
    Zhang W; Liu Y; Hu H; Huang H; Bao Z; Yang P; Wang Y; You G; Yan W; Jiang T; Wang J; Zhang W
    PLoS One; 2015; 10(11):e0142856. PubMed ID: 26575197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progenitor-like traits contribute to patient survival and prognosis in oligodendroglial tumors.
    Ng FS; Toh TB; Ting EH; Koh GR; Sandanaraj E; Phong M; Wong SS; Leong SH; Kon OL; Tucker-Kellogg G; Ng WH; Ng I; Tang C; Ang BT
    Clin Cancer Res; 2012 Aug; 18(15):4122-35. PubMed ID: 22675171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CDC20 with malignant progression and poor prognosis of astrocytoma revealed by analysis on gene expression.
    Ding Y; Yu S; Bao Z; Liu Y; Liang T
    J Neurooncol; 2017 May; 133(1):87-95. PubMed ID: 28432586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of multiple larger-sized transcripts for several genes in oligodendrogliomas: potential markers for glioma subtype.
    Xu X; Joh HD; Pin S; Schiller NI; Prange C; Burger PC; Schiller MR
    Cancer Lett; 2001 Sep; 171(1):67-77. PubMed ID: 11485829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas.
    Han MZ; Huang B; Chen AJ; Zhang X; Xu R; Wang J; Li XG
    Oncol Rep; 2017 Feb; 37(2):903-912. PubMed ID: 28075478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High level of Sema3C is associated with glioma malignancy.
    Vaitkienė P; Skiriutė D; Steponaitis G; Skauminas K; Tamašauskas A; Kazlauskas A
    Diagn Pathol; 2015 Jun; 10():58. PubMed ID: 26032848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling.
    Tews B; Felsberg J; Hartmann C; Kunitz A; Hahn M; Toedt G; Neben K; Hummerich L; von Deimling A; Reifenberger G; Lichter P
    Int J Cancer; 2006 Aug; 119(4):792-800. PubMed ID: 16550607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.
    Castelo-Branco P; Choufani S; Mack S; Gallagher D; Zhang C; Lipman T; Zhukova N; Walker EJ; Martin D; Merino D; Wasserman JD; Elizabeth C; Alon N; Zhang L; Hovestadt V; Kool M; Jones DT; Zadeh G; Croul S; Hawkins C; Hitzler J; Wang JC; Baruchel S; Dirks PB; Malkin D; Pfister S; Taylor MD; Weksberg R; Tabori U
    Lancet Oncol; 2013 May; 14(6):534-42. PubMed ID: 23598174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression profiling with oligonucleotide microarrays distinguishes World Health Organization grade of oligodendrogliomas.
    Watson MA; Perry A; Budhraja V; Hicks C; Shannon WD; Rich KM
    Cancer Res; 2001 Mar; 61(5):1825-9. PubMed ID: 11280731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
    Zhang MY; Liu XX; Li H; Li R; Liu X; Qu YQ
    Int J Med Sci; 2018; 15(14):1676-1685. PubMed ID: 30588191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.